About
Pek Lum is the founder and CEO of Auransa Inc., a clinical-stage, AI-driven biopharmaceutical company developing therapies for cancers including liver, late-stage prostate, and head and neck cancer, as well as heart-safe chemotherapy. Prior to Auransa, she was one of the earliest members of Rosetta, a genomics technology company later acquired by Merck, where she worked to integrate data science into biological discovery. She has also participated in biopharma and data-focused startups as a founding team member or advisor, and advocates for AAPI and women founders.
Co-Founder & CEO at Auransa
Intro paths
→
In turn, Pek can intro founders to Auransa's investors below.
Experience
- Auransa Inc.Founder and CEOcurrent2014 — presentPalo Alto, CA
- CCB, Schaefer School of Engineering and Science at Stevens Institute of TechnologyExternal Advisory Board Member, Adjunct Professorcurrent2022 — presentNew Jersey, United States
- Sequence BioAdvisorcurrent2015 — presentGreater St. John's Metropolitan Area
- Bayes ImpactAdvisor2014 — 2019
- The Michael J. Fox Foundation for Parkinson's ResearchAdvisor2015 — 2016
- Resolution BioscienceAdvisory Board Member2013 — 2014
- U-BIOPREDAdvisor (Statistical Advisory Board)2014
- AyasdiChief Data Scientist and VP of Solutions2013 — 2014Palo Alto
- AyasdiVP, Product2010 — 2014Palo Alto
- iPierianSenior Director2009 — 2010
- Rosetta/MerckScientific Director1999 — 2009
Skills & more
People Skills2Collaborative Problem Solving1Genetics51Systems Biology29Data Mining21Inflammation4Stem Cells10Gene Expression4Bioinformatics11Neuroscience13Drug Discovery48Genomics53
+12 more
BiomarkersCancerProduct StrategiesCoaching for ExcellenceThinking Outside The BoxMolecular BiologyBiomarker DiscoverySequencingLifesciencesComputational BiologyMachine LearningInformaticsFrom Pek's professional profile.
Frequently asked questions
- Who is Pek Lum?
- Pek Lum is the founder and CEO of Auransa Inc., a clinical-stage, AI-driven biopharmaceutical company developing therapies for cancers including liver, late-stage prostate, and head and neck cancer, as well as heart-safe chemotherapy. Prior to Auransa, she was one of the earliest members of Rosetta, a genomics technology company later acquired by Merck, where she worked to integrate data science into biological discovery. She has also participated in biopharma and data-focused startups as a founding team member or advisor, and advocates for AAPI and women founders.
- Where does Pek Lum work?
- Pek Lum is Co-Founder & CEO of Auransa.
- What companies did Pek Lum found?
- Pek Lum founded Auransa.
- Where did Pek Lum go to school?
- Pek Lum studied at University of Washington (Ph.D., Molecular Biology); Hokkaido University (Master of Science (M.Sc.), Biochemistry); Hokkaido University (Bachelor of Science (B.Sc.), Biochemistry and Molecular Biology).
Same school
Also attended University of Washington367
Andrew ChenGeneral Partner at Andreessen HorowitzArvind JainFounder & CEO of GleanJane MooneyCo-founder & VP, Strategy and Finance at Collaborative RoboticsVictoria TreygerGeneral Partner at Felicis VenturesAndrewAdvisor at Clear VenturesRolanda FuInvestor at Madrona Venture Group
+ 361 more
Also attended Hokkaido University15
Keita NakanishiCEO at Yamaha Motor VenturesTaruho KurodaImpact Partner at Fresco CapitalTetsu NakajimaInvestor at 15th RockTakeshi MinamotoInvestor at 15th RockKota UnoPrincipal at GMO VenturePartnersDan GluckCo-Founder and Managing Partner at GroundForce Capital
+ 9 more
Also attended Tokyo University of Foreign Studies5
Shared employers
Also worked at Auransa Inc.1
Also worked at Sequence Bio2
Also worked at Bayes Impact1
Also worked at Rosetta/Merck139
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock VenturesDavid KaufmanInvestor at Third Rock Ventures
+ 133 more